TILT Holdings Inc. (“TILT” or the “Company”) (CSE:TILT, OTCMKTS:SVVTF), a foundational technology cannabis platform comprised of assets to support brands worldwide, announced today it has reached a milestone of supporting 2,000 brands across North America between three of its subsidiaries: Jupiter Research, LLC (“Jupiter”), Baker Technologies Inc. (“Baker”) and Blackbird Logistics Corporation (“Blackbird”). The company also announced the full integration of Baker’s toolset into Blackbird’s inventory management platform and e-commerce offerings.

“Supporting 2,000 brands is a major milestone for TILT and its subsidiaries,” said Mark Scatterday, Interim CEO of TILT Holdings. “Achieving this number is a testament to TILT’s commitment to providing value to cannabis retailers through technology, hardware and software solutions. The full integration of Baker into Blackbird provides a large scale benefit to our wholesale and retail customers by providing them the tools they need to be successful in customer relations management and cannabis distribution.”


TILT’s milestone of supporting 2,000 brands across North America comes as a result of the Company’s ongoing efforts to provide the cannabis industry with comprehensive solutions through its subsidiary brands. Jupiter is a leading inhalation hardware company that produces award-winning vaporizer platforms and sells wholesale products to cannabis brands across the globe. Baker is a leading customer relationship management (“CRM”) platform for the cannabis industry that helps dispensaries grow their business and build relationships with their customers, and services dispensaries throughout the United States, Canada, Jamaica, and Puerto Rico. Blackbird provides operations and software solutions to facilitate the movement of cannabis products at each touchpoint in the supply chain for dispensaries in California and Nevada.

The complete integration of Baker’s toolset into the Blackbird platform will extend the support that both companies can provide to retailers by connecting them to consumers in a more substantial and comprehensive way. Together, these operations should help solve issues many companies have within the cannabis distribution process and bring additional expertise and knowledge to the cannabis industry.

To learn more about TILT Holdings, Inc. visit www.tiltholdings.com. For more information about Baker, visit www.trybaker.com.

About TILT

TILT Holdings serves cannabis brands worldwide through a strong network of portfolio companies committed to technological innovations that support long-term success. TILT services more than 2,000 brands and cannabis retailers across 33 states in the U.S., as well as in Canada, Israel, Mexico, South America and the European Union. As a market leader in cannabis technology and related products and services, the Company’s core assets include wholly-owned subsidiaries Jupiter, a company that focuses on the vast potential of inhalation through innovative design, development and manufacturing; Blackbird, a company that provides operations and software solutions for wholesale and retail distribution; and Baker, a CRM platform helping dispensaries grow their business. The Company also owns cannabis operations in states including Massachusetts, led by Commonwealth Alternative Care, Inc.; and in Pennsylvania, led by Standard Farms, LLC. Headquartered in Cambridge, Massachusetts, with offices throughout the U.S., and London, TILT has over 400 employees and has sales in the U.S., Canada and Europe. For more information, visit www.tiltholdings.com.

Click here to connect with TILT Holdings (CSE: TILT, OTCQB: SVVTF) for an Investor Presentation

 

Source: www.businesswire.com

NYSE | TSX: ACB

Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on bought deal basis 12,000,000 units of the Company (the “Units”), at a price of US$10.45 per Unit for gross proceeds of approximately US$125 million (the “Offering”). Each Unit will be comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant will be exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /

Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less